Details

• Title:

  Grant Applications (CGA) on Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)

• Type:

  Grant

• Donor:

  Pfizer

• Status:

  Accepting Bids

• Deadline:

  06 Sep 2026

• Duration:

  4 months

• Value:

  Total estimated budget: US $450,000

• Locations:

  MENA region

• Sectors:

  Health

• Sub sectors:

  Health research, Prevention of non-communicable diseases

• Type of Services:

  Capacity building and training, Research and assessment

• Sub Services:

  Scientific research, Training workshops

• Attachments:

• Post Date

  10 Aug 2026

• Contact information